市場調查報告書
商品編碼
1465109
微創手術市場:按類型、技術和最終用戶分類 - 全球預測 2024-2030Minimally Invasive Surgery Market by Type (Cardiovascular Surgery, Cosmetic Surgery, Gastrointestinal Surgery), Technology (Endoscopic Surgery, Laparoscopy, Laser & Microsurgery), End Users - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年微創手術市場規模為719.6億美元,2024年達812.1億美元,預計2030年將達到1723.7億美元,複合年成長率為13.28%。
微創手術是一種透過小切口而不是大開口進行的外科手術。這種方法使用特殊的儀器和攝影機來指導手術,因此與傳統的開放性手術相比,患者會經歷更少的疼痛、更少的疤痕和更快的恢復。患者越來越傾向於選擇對身體和日常生活干擾最小化的手術,而微創技術的採用正在推廣。微創手術通常會縮短住院時間並加快復原時間,從而顯著降低患者和保險公司的醫療費用。政府努力提高接受手術干預的患者的便利性並降低醫療保健服務的成本,這使得微創手術得到了更多的採用。然而,微創手術器械的複雜設計和操作需要大量的培訓和技能,這對其普及提出了挑戰。感染疾病風險、健康風險和保險範圍的複雜性也會阻礙微創手術和設備的普及。機器人手術的不斷進步預計將提高手術過程的精確度和靈活性,使微創手術適用於更廣泛的情況,並提高手術介入的安全性和效率。重點培訓醫療保健專業人員進行微創手術有可能縮小技能差距並改善手術結果。手術資料和數位醫療記錄的整合有可能顯著改善術後監測和個人化患者照護,從而最大限度地發揮微創手術的優勢。
主要市場統計 | |
---|---|
基準年[2023] | 719.6億美元 |
預測年份 [2024] | 812.1億美元 |
預測年份 [2030] | 1723.7億美元 |
複合年成長率(%) | 13.28% |
類型:整形外科手術採用微創手術,保證疼痛少、恢復快、疤痕少
在心血管治療中,微創手術用於透過較小的切口解決心臟和血管問題。手術包括心臟瓣膜修復、冠狀動脈繞道手術和心臟缺陷修復。其目的是透過減少恢復時間和併發症來減少心血管手術對患者的侵入性。美容微創手術的重點是改善您的外表,同時盡可能減少對身體的影響。從肉毒桿菌注射到抽脂再到拉皮,一切都是透過微小的切口和儀器完成的。這種方法可以減少疤痕和恢復時間,使整容手術更容易進行且風險更低。胃腸手術涉及使用微創技術對胃腸道進行手術,包括食道、胃、小腸、大腸和直腸。它可以治療疝氣、膽囊結石和胃腸道癌症等疾病。這種方法旨在最大程度地減少術後不適並儘早恢復正常活動。婦科手術中的微創技術可解決女性生殖系統疾病。常見的手術包括子宮肌瘤、卵巢囊腫、子宮內膜異位症和子宮切除術(切除子宮)。這些方法有助於縮短癒合時間並改善女性的整體手術體驗。整形外科專注於與肌肉骨骼系統相關的疾病。微創技術應用於關節重建、軟組織損傷修復和骨骼畸形矯正。由於切口小,組織損傷少,恢復快,術後疼痛也少。微創泌尿系統手術治療影響泌尿道和男性生殖器官的疾病,包括腎結石清除、攝護腺手術和癌症治療等手術和外科介入。腹腔鏡手術和機器人輔助手術等技術透過降低手術侵入性來改善泌尿系統護理。
最終使用者:世界各地更多的醫院可以提供即時、全面的術後護理
門診手術中心 (ASC) 是進行不需要長期住院的手術的設施。這些中心專門為患者提供手術服務,包括微創手術,讓您在手術後當天就可以回家。出於對效率和成本效益的關注,ASC 擴大在各種手術中採用微創手術技術,特別是那些被認為具有中度至低複雜度的手術。由於 ASC 的性質,微創手術的使用很重要,因為 ASC 更喜歡恢復時間更快的手術。醫院手術覆蓋範圍最廣,既有微創手術,也有傳統的開放性手術。該醫院配備了先進的醫療設備,並由多元化的專家團隊管理,使我們能夠執行從基本到最複雜的各種微創外科手術。醫院可以說是微創手術最通用的場所,因為它們擁有豐富的資源,例如專業手術室和復健室。我們處理各種患者群體,包括緊急手術、複雜手術以及需要術後護理的手術。功能齊全的醫院很可能是MIS的主要場所,特別是在進行需要術後後續觀察或複雜的手術時。專科診所是專門從事特定醫療領域並提供有針對性的護理的醫療機構,例如與專科相關的診斷服務、治療和手術。在微創手術中,專科診所通常專注於其專業內的特定微創手術,例如整形外科、婦科或胃腸科。儘管專科診所在其專業領域廣泛使用微創手術技術,但微創手術在整個潛在手術範圍內的整體使用自然受到醫院的限制,並且相比而言也有限。
區域洞察
美洲,特別是美國和加拿大,由於其完善的醫療基礎設施、較高的患者意識和較高的醫療費用,處於最新微創手術技術的前沿。消費者的需求很大程度上是由對更快的恢復時間和更少的侵入性治療方法的渴望所驅動的。該地區持續的研究投資創造了強大的創新和專利管道,以提高手術精度並減少創傷。最近的努力包括整合機器人技術和人工智慧 (AI),以進一步改善手術結果。由於人口老化和對高品質醫療保健標準的承諾,歐洲代表了微創手術的成熟環境。政府和私人為醫療保健研究提供了大量資金,重點是增強手術工具和技術。此外,有關醫療設備和器械的開發、效率、安全性和可靠性的嚴格法規的存在,為微創手術設備和解決方案創建了標準化框架,並形成了安全醫療產品的開發環境。在亞太地區,由於醫療成本不斷上升、中階人口不斷成長以及醫院數量不斷增加,對微創手術解決方案的需求正在顯著增加。在中國和印度,政府改善衛生服務的努力和增加衛生部門的外國投資正在提供重大推動力。日本以其技術進步而聞名,是手術機器人開發的主要創新者。患者對具有成本效益且負擔得起的外科手術的偏好以及政府對改善公共衛生的支持為採用微創手術解決方案創造了有利條件。
FPNV定位矩陣
FPNV定位矩陣對於評估微創手術市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對微創手術市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.微創手術市場的市場規模與預測是多少?
2.微創手術市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些?
3.微創手術市場的技術趨勢和法規結構是什麼?
4.微創手術市場主要廠商的市場佔有率為何?
5.進入微創手術市場合適的形式和策略手段是什麼?
[197 Pages Report] The Minimally Invasive Surgery Market size was estimated at USD 71.96 billion in 2023 and expected to reach USD 81.21 billion in 2024, at a CAGR 13.28% to reach USD 172.37 billion by 2030.
Minimally invasive surgery is a surgical intervention that is performed through tiny incisions instead of large openings. This approach utilizes specialized instruments and a camera to guide the surgery, making it possible for patients to experience less pain, reduced scarring, and a quicker patient recovery time compared to traditional open surgery. There is a growing preference among patients for surgeries that cause minimal disruption to their bodies and lives, driving the adoption of minimally invasive techniques. Minimally invasive surgeries often result in shorter hospital stays and quicker recoveries, which can significantly reduce healthcare costs for patients and insurance providers. Government initiatives to improve the accessibility of patients for surgical interventions and lower the cost of medical services have led to the growing adoption of minimally invasive surgeries. However, the intricate design and operation of minimally invasive surgical tools require significant training and skill, which can pose a challenge in their widespread adoption. The risk of infection, health risks, and complexities associated with insurance coverage can hamper the adoption of minimally invasive surgeries and instruments. Continued advancements in robotic surgery are expected to enhance precision and flexibility during operations, making minimally invasive procedures accessible for a wider range of conditions and also improving the safety and efficiency of surgical interventions. Increased focus on training healthcare professionals in minimally invasive techniques can reduce the skill gap, improving surgical outcomes. The integration of surgical data with digital health records could greatly improve post-surgery monitoring and personalized patient care, maximizing the benefits of minimally invasive procedures.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 71.96 billion |
Estimated Year [2024] | USD 81.21 billion |
Forecast Year [2030] | USD 172.37 billion |
CAGR (%) | 13.28% |
Type: Adoption of minimally invasive surgeries for orthopedic procedures to ensure less pain, quicker recovery, and minimal scarring
In cardiovascular care, minimally invasive surgery is used to address heart and blood vessel issues with smaller incisions. Procedures can include heart valve repairs, coronary artery bypass, and heart defect repairs. The aim is to reduce recovery time and complications, making heart surgery less daunting for patients. Cosmetic minimally invasive surgeries focus on enhancing appearance with the least possible disruption to the body. These can range from botox injections to liposuction and facelifts performed with tiny incisions and instruments. This approach reduces scarring and recovery periods, making cosmetic improvements more accessible and less risky. Gastrointestinal surgery involves surgeries of the digestive tract, including the esophagus, stomach, small intestine, large intestine, and rectum, utilizing minimally invasive techniques. Conditions such as hernias, gallbladder stones, and gastrointestinal cancers can be treated. The approach seeks to minimize post-operative discomfort and facilitate a quicker return to normal activities. Minimally invasive techniques in gynecological surgery address disorders of the female reproductive system. Common procedures include treatments for uterine fibroids, ovarian cysts, endometriosis, and hysterectomies (removal of the uterus). These methods help in reducing the healing time and improving the overall surgical experience for women. Orthopedic surgery focuses on conditions involving the musculoskeletal system. Minimally invasive techniques can be applied in joint replacements, repairing soft tissue injuries, and correcting bone deformities. Smaller incisions result in lesser tissue damage, leading to quicker recovery times and diminished pain post-operation. Urological minimally invasive surgeries treat conditions affecting the urinary tract and male reproductive organs, including procedures and surgical interventions such as kidney stone removal, prostate surgery, and cancer treatments. Techniques such as laparoscopy and robotic-assisted surgery have improved urology care by making surgeries less invasive.
End Users: Expansion of hospitals across the world owing to their capacity to provide immediate, comprehensive post-operative care
Ambulatory surgical centers(ASC) refer to facilities where surgeries that do not need long hospital admission are performed. These centers specialize in providing surgical services, including minimally invasive surgery, to patients who can go home on the same day of their procedure. Given their focus on efficiency and cost-effectiveness, ASCs have increasingly adopted minimally invasive surgery techniques for a variety of procedures, particularly those deemed low to moderate in complexity. Their usage of minimally invasive surgery is significant due to the nature of ASC favoring surgeries with quicker recovery times. Hospitals encompass the broadest range of surgeries, including both minimally invasive and traditional open surgeries. They are equipped with advanced medical facilities and staffed by a diverse team of specialists, allowing them to perform a wide array of minimally invasive surgery procedures, from basic to highly complex. Hospitals are arguably the most versatile settings for minimally invasive surgery due to their extensive resources, including specialized surgery rooms and recovery units. They cater to a wide patient demographic, handling emergency surgeries, complicated procedures, and surgeries requiring extensive post-operative care. Given their comprehensive capabilities, hospitals are likely the primary setting for MIS, particularly for procedures that demand significant post-surgery monitoring or entail high complexity. Specialty clinics are healthcare facilities focusing on a specific field of medicine, providing targeted care, including diagnostic services, treatment, and surgeries related to their area of specialization. For minimally invasive surgery, specialty clinics often concentrate on specific types of minimally invasive procedures that fall within their expertise, such as orthopedics, gynecology, or gastroenterology. While specialty clinics extensively use minimally invasive surgery techniques within their focus areas, their overall use of minimally invasive surgery across the full spectrum of potential procedures is naturally more limited compared to hospitals due to their specialized nature.
Regional Insights
The Americas region, particularly the United States and Canada, is at the forefront in adopting the latest minimally invasive surgical technologies due to their well-established healthcare infrastructure, high patient awareness, and significant healthcare spending. The consumer need is largely driven by the desire for quicker recovery times and less invasive treatment options. The region experiences continuous investment in research, leading to a robust pipeline of innovations and patents designed to make surgeries more precise and less traumatic. Recent initiatives include the integration of robotics and artificial intelligence (AI) to further refine surgical outcomes. Europe represents a mature landscape for minimally invasive surgery, prompted by both the growing aging population and the region's commitment to high-quality healthcare standards. Government and private funding in healthcare research are substantial, focusing on enhancing surgical tools and methodologies. Moreover, the presence of stringent regulations pertaining to the development, efficiency, safety, and reliability of medical equipment and devices has created a standardized framework for minimally invasive surgical equipment and solutions, creating a ripe landscape for the development of safe medical products. The APAC region is witnessing a significant surge in the need for minimally invasive surgery solutions, attributed to rising healthcare expenditures, growing middle-class populations, and an increasing number of hospitals. In China and India, government initiatives aimed at enhancing healthcare services and increasing foreign investments in the medical sector provide a considerable push. Japan, known for its technological advancements, is a key innovator in developing surgical robotics. Patient preference for cost-effective and affordable surgical interventions and government support for improving public health has created a conducive landscape for the adoption of minimally invasive surgery solutions.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Minimally Invasive Surgery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Minimally Invasive Surgery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Minimally Invasive Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Arthrex, Inc., B. Braun SE, Boston Scientific Corporation, Conmed Corporation, Cook Group Incorporated by The Cooper Companies, Inc., Danaher Corporation, FUJIFILM Corporation, GE HealthCare Technologies Inc., Getinge AB, Hoya Corporation, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, Koninklijke Philips N.V., Livanova PLC, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Siemens Healthineers, Smith & Nephew plc, Stryker Corporation, Synaptive Medical Inc., Teleflex Incorporated, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Minimally Invasive Surgery Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Minimally Invasive Surgery Market?
3. What are the technology trends and regulatory frameworks in the Minimally Invasive Surgery Market?
4. What is the market share of the leading vendors in the Minimally Invasive Surgery Market?
5. Which modes and strategic moves are suitable for entering the Minimally Invasive Surgery Market?